Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

BioLineRx presents positive results from phase IIa interim trial of BL-1020 for schizophrenia

Nov. 5, 2007

Addrenex and Sciele initiate phase III trials for Clonicel

Nov. 5, 2007

Vanda presents top-line results of phase II trial of VSF-173 for excessive sleepiness

Nov. 5, 2007

Taisho and Pfizer sign letter of intent for schizophrenia drug candidate

Nov. 5, 2007

Eisai delays filing of regulatory submission of E-2007 until the fourth quarter of 2008

Nov. 5, 2007

Santhera reports positive results from phase IIa trial of SNT-MC17

Nov. 5, 2007

In vivo antinociceptive effects reported for novel alpha2-adrenoceptor agonist

Nov. 5, 2007

Studies detail efficacy of sugammadex in reversing neuromuscular blockade

Nov. 5, 2007

Recent GSK and Mochida patents report novel analgesic agents

Nov. 5, 2007

Novel candidate gene for Parkinson's disease identified

Nov. 5, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...